抗体
选项
-
Secukinumab (anti-IL-17A)关联靶标: IL17A
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 1229022-83-6 -
Ixekizumab (anti-CTLA-8)关联靶标: IL17A
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Human IgG4SP
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 1143503-69-8 -
Vunakizumab (anti-IL-17a)关联靶标: IL17A
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 大鼠(Rat), 小鼠(Mouse), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 1792181-33-9 -
PIP4K2A Antibody关联靶标: PIP4K2A
- 简短描述: pAb; Rabbit anti Human PIP4K2A Antibody; WB, IF/ICC, IHC, Flow; Unconjugated
- 种属反应性: 人(Human), 大鼠(Rat), 小鼠(Mouse)
- 亚型: Rabbit IgG
- 宿主种属: 兔(Rabbit)
- 偶联: Unconjugated
-
Ruplizumab (anti-CD40L)关联靶标: CD40LG
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 220651-94-5 -
Toralizumab (anti-CD40L)关联靶标: CD40LG
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 252662-47-8分子量: 148.43 (kD)SMILES: [Toralizumab] -
Letolizumab (anti-TNFSF5)关联靶标: CD40LG
- 简短描述: Purity≥95% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; VHH-Fc; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 亚型: VHH-Fc
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 1450981-87-9 -
CD154/CD40L Mouse mAb关联靶标: CD40LG
- 简短描述: mAb (5C8); Mouse anti Human/Monkey CD154/CD40L Antibody; in vitro blocking of CD40/CD40L signaling, in vivo blocking of CD40/CD40L signaling, IP, Flow; Unconjugated
- 种属反应性: 人(Human), 猴(Monkey)
- 亚型: Mouse IgG2a
- 宿主种属: 小鼠(Mouse)
- 克隆号: 5C8
- 偶联: Unconjugated
-
Frexalimab (anti-CD40L)关联靶标: CD40LG
- 简短描述: Purity≥95% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 2515463-86-0SMILES: [Frexalimab] -
Dapirolizumab (anti-CD40L)关联靶标: CD40LG
- 简短描述: Purity≥95% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
-
Netakimab (anti-IL-17A)关联靶标: IL17A
- 简短描述: Purity≥95% (SDS-PAGE&SEC); Endotoxin Level <0.01EU/μg ; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 1796570-08-5 -
Xeligekimab (anti-IL-17A)关联靶标: IL17A
- 简短描述: Purity≥95% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 小鼠(Mouse), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG4SP
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 2382921-73-3
首页
400-620-6333











